Eye Disease News and Research

RSS
Eye diseases are widespread around the globe. According to the World Health Organization, the most important three eye diseases or conditions that are a potential threat to the global population are diabetic retinopathy, glaucoma, and age-related macular degeneration. One more vital reason for visual harm is refractive errors. Some of the important reasons for vision loss or low vision are age, healthcare, gender, genetic problems and the prevalence of family history.
Fatty acid combination supplement improves visual function in preterm babies

Fatty acid combination supplement improves visual function in preterm babies

Low-dose atropine eyedrops not effective in slowing myopia progression in children

Low-dose atropine eyedrops not effective in slowing myopia progression in children

Biomimetic materials pulsed with low-energy blue light can reshape damaged corneas

Biomimetic materials pulsed with low-energy blue light can reshape damaged corneas

Discovery redefines current understanding of immune cell landscape in the human cornea

Discovery redefines current understanding of immune cell landscape in the human cornea

Mobile app uses AI to detect eye diseases

Mobile app uses AI to detect eye diseases

Study reveals how to customize artificial tears to alleviate dry eye symptoms

Study reveals how to customize artificial tears to alleviate dry eye symptoms

Mount Sinai launches first-of-its-kind center for ophthalmic AI

Mount Sinai launches first-of-its-kind center for ophthalmic AI

Oral probiotic bacterial strain found to improve dry eye disease in animal model

Oral probiotic bacterial strain found to improve dry eye disease in animal model

Research finds link between biomarkers in vitreous humor of the eye and Alzheimer's disease

Research finds link between biomarkers in vitreous humor of the eye and Alzheimer's disease

A more aggressive FTC is starting to target drug mergers and industry middlemen

A more aggressive FTC is starting to target drug mergers and industry middlemen

The drug company that prospered without creating any drugs

The drug company that prospered without creating any drugs

Scientists secure funding for cutting-edge research on age-related macular degeneration

Scientists secure funding for cutting-edge research on age-related macular degeneration

Membrane attack complex could be a potential therapeutic target to slow or prevent AMD

Membrane attack complex could be a potential therapeutic target to slow or prevent AMD

Using nanoparticles to encapsulate the medication may make corneal grafts more successful

Using nanoparticles to encapsulate the medication may make corneal grafts more successful

Study investigates anti-VEGF treatment for inflammatory eye disease in HTLV-1–infected ocular cells

Study investigates anti-VEGF treatment for inflammatory eye disease in HTLV-1–infected ocular cells

Researchers aim to better understand how myopia management strategies affect children

Researchers aim to better understand how myopia management strategies affect children

Study identifies a previously unknown role of 'natural killer' immune cells

Study identifies a previously unknown role of 'natural killer' immune cells

In the wake of Chantix's recall, Varenicline use for nicotine dependence dropped by 75%

In the wake of Chantix's recall, Varenicline use for nicotine dependence dropped by 75%

Early treatment of diabetes-related eye disease does not improve visual acuity

Early treatment of diabetes-related eye disease does not improve visual acuity

Researchers identify a new genetic risk factor for age-related macular degeneration

Researchers identify a new genetic risk factor for age-related macular degeneration

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.